/Committee for Medicinal Products for Human Use (CHMP): 23-26 February 2026, European Medicines Agency, Amsterdam, the Netherlands, from 23 February 2026 to 26 February 2026
NEWS

Committee for Medicinal Products for Human Use (CHMP): 23-26 February 2026, European Medicines Agency, Amsterdam, the Netherlands, from 23 February 2026 to 26 February 2026

EMA
2026/08/27

Date

Monday, 23 February

Thursday, 26 February 2026

,

All day

Location

European Medicines Agency, Amsterdam, the Netherlands

The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.

Documents

Agenda of the CHMP meeting 23-26 February 2026

Draft

Reference Number:

EMA/CHMP/41571/2026

English (EN) (576.23 KB - PDF)

First published:

23/02/2026

View

Annex to agenda of the CHMP meeting 23-26 February 2026

Reference Number:

EMA/CHMP/20183/2026

English (EN) (133.81 KB - XLSX)

First published:

23/02/2026

View

Minutes of the CHMP meeting 23-26 February 2026

Adopted

Reference Number:

EMA/CHMP/140189/2026

English (EN) (722.83 KB - PDF)

First published:

27/08/2026

View

Annex to 23-26 February 2026 CHMP Minutes

Reference Number:

EMA/CHMP/49160/2026

English (EN) (140.13 KB - XLSX)

First published:

27/08/2026

View

Related information

Summary

Committee for Medicinal Products for Human Use (CHMP): 23-26 February 2026, European Medicines Agency, Amsterdam, the Netherlands, from 23 February 2026 to 26 February 2026